Skip to content
TrialScanner

NCT06037577

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Phase 1CompletedCMMBLead

Registry record

Lead sponsor
ChemomAb Ltd.
Conditions
Nonalcoholic Steatohepatitis (NASH); Primary Sclerosing Cholangitis (PSC); Systemic Sclerosis (SSc)
Primary completion
May 5, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06037577 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.